Nov 7, 2024   SOURCE: PR NewsWire

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Financial release accessible online

BOSTON, Nov. 7, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2025, which ended September 28, 2024, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on November 7, 2024. The conference call and webcast can be accessed with the following information:

    --  Teleconference link:
        https://register.vevent.com/register/BI3c9f473811f94c489025845778f9dabc
    --  Once registration is completed, participants will receive a dial-in
        number along with a personalized PIN to access the call. While not
        required, it is recommended that participants join 10 minutes prior to
        the event start.
    --  A live webcast of the call can be accessed on Haemonetics' investor
        relations website or via the following link:
        https://edge.media-server.com/mmc/p/rcm5foqd

In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.

Direct link to 2Q FY25 Earnings Release:
https://haemonetics.gcs-web.com/static-files/a28cb934-1e51-4489-9c9f-1a3f68dc7f5a

A replay of the conference call and webcast will be available for one year beginning on November 7, 2024, at 11:00 a.m. ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.



     
              Investor Contacts:



     Olga Guyette, Vice President-Investor Relations & Treasury   David Trenk, Manager-Investor
                                                                    Relations



     (781) 356-9763                                             
     (203) 733-4987



     
              olga.guyette@haemonetics.com                                 david.trenk@haemonetics.com




              
                Media Contact:



              Josh Gitelson, Sr. Director-Global Communications



              (781) 356-9776



              
                josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-2nd-quarter-fiscal-year-2025-earnings-release-available-on-investor-relations-website-302298494.html

SOURCE Haemonetics Corporation